Alyeska Investment Group’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $189M | Buy |
2,217,425
+543,623
| +32% | +$48.5M | 0.53% | 37 |
|
|
2025
Q4 | $132M | Buy |
+1,673,802
| New | +$131M | 0.37% | 65 |
|
|
2024
Q3 | – | Sell |
-294,177
| Closed | -$28.5M | – | 552 |
|
|
2024
Q2 | $28.5M | Sell |
294,177
-430,936
| -59% | -$39.8M | 0.16% | 173 |
|
|
2024
Q1 | $65.3M | Sell |
725,113
-430,925
| -37% | -$36.5M | 0.4% | 81 |
|
|
2023
Q4 | $92.1M | Buy |
1,156,038
+236,981
| +26% | +$17.8M | 0.61% | 46 |
|
|
2023
Q3 | $65.4M | Sell |
919,057
-217,571
| -19% | -$16.3M | 0.44% | 73 |
|
|
2023
Q2 | $87.6M | Buy |
1,136,628
+658,364
| +138% | +$51M | 0.65% | 33 |
|
|
2023
Q1 | $35.9M | Sell |
478,264
-146,736
| -23% | -$10.9M | 0.31% | 103 |
|
|
2022
Q4 | $49.2M | Buy |
+625,000
| New | +$46.9M | 0.51% | 69 |
|
|
2021
Q3 | – | Sell |
-205,000
| Closed | -$16.7M | – | 696 |
|
|
2021
Q2 | $16.7M | Buy |
+205,000
| New | +$16.8M | 0.19% | 151 |
|
|
2020
Q3 | – | Sell |
-354,724
| Closed | -$26M | – | 481 |
|
|
2020
Q2 | $26M | Sell |
354,724
-504,945
| -59% | -$35.9M | 0.39% | 81 |
|
|
2020
Q1 | $57M | Sell |
859,669
-133,913
| -13% | -$9.44M | 1.14% | 16 |
|
|
2019
Q4 | $68.4M | Buy |
993,582
+297,587
| +43% | +$20.3M | 0.9% | 27 |
|
|
2019
Q3 | $51.2M | Buy |
+695,995
| New | +$50.5M | 0.74% | 36 |
|
|
2018
Q2 | – | Sell |
-1,103,866
| Closed | -$79.1M | – | 466 |
|
|
2018
Q1 | $79.1M | Sell |
1,103,866
-792,358
| -42% | -$57M | 0.66% | 49 |
|
|
2017
Q4 | $143M | Buy |
1,896,224
+226,036
| +14% | +$16.5M | 1.14% | 16 |
|
|
2017
Q3 | $122M | Buy |
1,670,188
+419,239
| +34% | +$30.2M | 0.91% | 18 |
|
|
2017
Q2 | $92.7M | Sell |
1,250,949
-165,344
| -12% | -$12.3M | 0.78% | 30 |
|
|
2017
Q1 | $104M | Buy |
1,416,293
+625,782
| +79% | +$43.8M | 0.84% | 22 |
|
|
2016
Q4 | $51.7M | Buy |
790,511
+223,235
| +39% | +$15.3M | 0.43% | 77 |
|
|
2016
Q3 | $42.1M | Buy |
+567,276
| New | +$41.9M | 0.39% | 80 |
|
|
2014
Q3 | – | Sell |
-96,520
| Closed | -$6.58M | – | 394 |
|
|
2014
Q2 | $6.58M | Sell |
96,520
-132,326
| -58% | -$8.87M | 0.15% | 199 |
|
|
2014
Q1 | $14.8M | Buy |
+228,846
| New | +$14.4M | 0.41% | 89 |
|
|
2013
Q4 | – | Sell |
-129,009
| Closed | -$7.65M | – | 314 |
|
|
2013
Q3 | $7.65M | Buy |
+129,009
| New | +$7.64M | 0.31% | 111 |
|
Other funds holding CL
VCM
DAM
VPM
Alyeska Investment Group's CL Position: Q1 2026 in Review
Alyeska Investment Group increased its Colgate-Palmolive (CL) stake by 32% in Q1 2026, buying an estimated $48.5M and bringing the position to 2,217,425 shares worth $189M. The position accounts for 0.53% of the portfolio, ranked #37.
Alyeska Investment Group first reported a position in CL in Q3 2013 and has held it in 24 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Alyeska Investment Group held 2,217,425 shares of Colgate-Palmolive worth $189M as of Q1 2026.
- Alyeska Investment Group bought 543,623 Colgate-Palmolive shares in Q1 2026, an estimated $48.5M.
- Colgate-Palmolive made up 0.53% of Alyeska Investment Group's portfolio in Q1 2026, its #37 holding.
- Alyeska Investment Group first reported a position in Colgate-Palmolive in Q3 2013 and has held it in 24 quarters since.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.